Whether you need IND-enabling animal studies, vaccine testing, or any other type of nonclinical safety assessment, you can accelerate your toxicology research by outsourcing with the Science Exchange Contracted™ network of verified providers.
Here are four recent additions to the network who can help advance your discovery and development programs — no additional MTAs, CDAs, or NDAs required.
Based in Missouri, USA, Sinclair Research Center is a nonclinical contract research organization (CRO) offering animal efficacy models, PK/PD evaluations and IND-enabling toxicology and safety pharmacology research services and capabilities.
Sinclair Research provides a wide range of nonclinical toxicology services (GLP and non-GLP) across all standard animal models, as well as rabbits, hamsters, and other models.
The team is experienced in handling small molecules, peptides, antibodies, proteins, antibody drug conjugates, viral vectors and cell & gene therapies that are being developed for a variety of human and animal health indications. Sinclair has board-certified toxicologists on staff to help determine the best nonclinical program for each therapeutic and ensure that it meets regulatory expectations.
Viroclinics Biosciences supports clinical and preclinical studies for drug and vaccine development for prevention and treatment of virus infections.
Viroclinics offers preclinical services including testing of efficacy, safety, PK and (immune) toxicology of drugs, antibodies, vaccines and antivirals targeting viral infectious diseases. The BSL-2 and BSL-3 facilities enable complicated experiments with highly pathogenic viruses.
Apart from the classical endpoints, the Viroclinics team can perform (histo) pathology of viral disease progression. Viroclinics offers validated assays to measure serological and cell mediated immune responses and custom-made assays as requested.
Immunocore reduces the cost and time of toxicology studies by using AI (artificial intelligence), ML (machine Learning), DL (deep learning), and CADD (computer-aided drug design) to predict the toxicity of drug candidates.
Immunocure has in-house AI tools, computational protocols, a large pool of compound databases with state-of-art infrastructure to predict various types of toxicity in the drug discovery pipeline, including cardiotoxicity, hepatotoxicity, renal toxicity, genotoxicity, carcinogenicity, and more.
STILLMEADOW, Inc., an independent CRO for product testing, provides the toxicology services needed for drug development, as well as for premanufacture notification, registration of pesticides, labeling and safe handling recommendations.
Not only can the STILLMEADOW team support acute and subchronic mammalian toxicology for IND-enabling studies, but they can also carry out avian toxicology, aquatic toxicology, entomology, and other environmental toxicology studies.